|
0
Votes
vote
FDA grants IND for Davanat to treat breast cancer patientPro-Pharmaceuticals, Inc. has announced that the U.S. Food and Drug Administration (FDA) has granted an Investigational New Drug (IND) application for use of Davanat in combination with 5-FU to treat a breast cancer patient at the Brown Cancer Center in Louisville, Kentucky. Davanat also is being... |
|
0
Votes
vote
FDA grants CLIA waiver to American Bio Medica for drug testAmerican Bio Medica Corporation has announced today that the US Food and Drug Administration (FDA) has granted CLIA waived status to the Company's Rapid TOX point of collection drug test product line. ... |
|
0
Votes
vote
FDA clears non-invasive test to help manage heart transplant patientsThe U.S. Food and Drug Administration has announced it has cleared for marketing a non-invasive test that uses molecular expression techniques to assist doctors in managing heart transplant patients post-surgery for potential organ rejection. ... |
|
0
Votes
vote
U.S. spinach and lettuce to be irradiated to stop outbreaks of foodborne bacteriaFollowing an increasing number of outbreaks of foodborne illnesses over the last few years, the Food and Drug Administration (FDA) in the United States is about to allow food producers to irradiate spinach and iceberg lettuce to kill foodborne bacteria. ... |
|
2
Votes
vote
FDA approves Nplate (romiplostim), first bone marrow stimulator for chronic immune thrombocytopenic purpuraThe U.S. Food and Drug Administration has approved Nplate (romiplostim), the first product that directly stimulates the bone marrow to produce needed platelets in patients with a rare blood disorder that can lead to serious bleeding. ... |
|
0
Votes
vote
Drug to Help Blood Clot Is ApprovedThe Food and Drug Administration approved Nplate for patients with a disorder that causes the body to attack its own platelets, tiny components of blood that help with clotting. ... |

